Extension of Time to File SOU

TUZEQUIVA

PRESTIGE BIOPHARMA PTE. LTD.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88106331
LAW OFFICE ASSIGNED LAW OFFICE 127
MARK SECTION
MARK http://uspto.report/TM/88106331/mark.png (stylized and/or with design)
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
OWNER SECTION (current)
NAME PRESTIGE BIOPHARMA PTE. LTD.
MAILING ADDRESS 2 Science Park Drive, #04-13 Ascent
CITY Singapore
ZIP/POSTAL CODE 118222
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Singapore
EMAIL XXXX
OWNER SECTION (proposed)
NAME PRESTIGE BIOPHARMA PTE. LTD.
MAILING ADDRESS 2 Science Park Drive, #04-13 Ascent
CITY Singapore
ZIP/POSTAL CODE 118222
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Singapore
EMAIL XXXX
ATTORNEY INFORMATION (current)
NAME Jonathan G. Morton
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
INTERNAL ADDRESS Suite 900
STREET 1395 Brickell Ave.
CITY Miami
STATE Florida
POSTAL CODE 33131
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 305-764-9179
EMAIL jmlawchina@gmail.com
ATTORNEY INFORMATION (proposed)
NAME Jonathan G. Morton
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
STREET 8D Dempsey Road #03-02A
CITY Singapore
POSTAL CODE 249672
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Singapore
PHONE +1-305-764-9179
EMAIL jmlawchina@gmail.com
CORRESPONDENCE INFORMATION (current)
NAME Jonathan G. Morton
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE jmlawchina@gmail.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) fstrademark@sina.com; huigangoffice@foxmail.com; zhangariel69@gmail.com
CORRESPONDENCE INFORMATION (proposed)
NAME Jonathan G. Morton
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE jmlawchina@gmail.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) fstrademark@sina.com; huigangoffice@foxmail.com; zhangariel69@gmail.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Biological preparations for the treatment of cancer; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medicinal preparations for cancer; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development ; market research ; steps to acquire distributors
ALLOWANCE MAIL DATE 04/02/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Jonathan G. Morton/
SIGNATORY'S NAME Jonathan G. Morton
SIGNATORY'S POSITION Attorney of record, New York Bar member
DATE SIGNED 03/30/2020
SIGNATORY'S PHONE NUMBER 305-764-9179
FILING INFORMATION
SUBMIT DATE Mon Mar 30 00:17:47 ET 2020
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XXX-
20200330001747467533-8810
6331-7103fb729d9ddb8edb6c
e471416987b4d3b3c9ccb2213
abfc28236fd3e0225e90-CC-1
7455289-20200330000203122
103



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: TUZEQUIVA (stylized and/or with design, see http://uspto.report/TM/88106331/mark.png)
SERIAL NUMBER: 88106331

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: PRESTIGE BIOPHARMA PTE. LTD., having an address of
      2 Science Park Drive, #04-13 Ascent
      Singapore, 118222
      Singapore
      Email: XXXX
Proposed: PRESTIGE BIOPHARMA PTE. LTD., having an address of
      2 Science Park Drive, #04-13 Ascent
      Singapore, 118222
      Singapore
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 04/02/2019.

For International Class 005:
Current identification: Biological preparations for the treatment of cancer; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medicinal preparations for cancer; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development ; market research ; steps to acquire distributors

The applicant's current Attorney Information:
      Jonathan G. Morton
      Suite 900
      1395 Brickell Ave.
      Miami, Florida 33131
      United States
      Phone: 305-764-9179
      Email: jmlawchina@gmail.com


The applicant's proposed Attorney Information:
      Jonathan G. Morton
      
      8D Dempsey Road #03-02A
      Singapore, 249672
      Singapore
      Phone: +1-305-764-9179
      Email: jmlawchina@gmail.com


Correspondence Information (current):
      Jonathan G. Morton
      PRIMARY EMAIL FOR CORRESPONDENCE: jmlawchina@gmail.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): fstrademark@sina.com; huigangoffice@foxmail.com; zhangariel69@gmail.com

Correspondence Information (proposed):
      Jonathan G. Morton
      PRIMARY EMAIL FOR CORRESPONDENCE: jmlawchina@gmail.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): fstrademark@sina.com; huigangoffice@foxmail.com; zhangariel69@gmail.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Jonathan G. Morton/      Date Signed: 03/30/2020
Signatory's Name: Jonathan G. Morton
Signatory's Position: Attorney of record, New York Bar member
Signatory's Phone: 305-764-9179

Mailing Address:
   
   
   8D Dempsey Road #03-02A
   Singapore, 249672

RAM Sale Number: 88106331
RAM Accounting Date: 03/30/2020

Serial Number: 88106331
Internet Transmission Date: Mon Mar 30 00:17:47 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-202003300017474
67533-88106331-7103fb729d9ddb8edb6ce4714
16987b4d3b3c9ccb2213abfc28236fd3e0225e90
-CC-17455289-20200330000203122103




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed